1. Home
  2. XENE vs HIW Comparison

XENE vs HIW Comparison

Compare XENE & HIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • HIW
  • Stock Information
  • Founded
  • XENE 1996
  • HIW 1978
  • Country
  • XENE Canada
  • HIW United States
  • Employees
  • XENE N/A
  • HIW N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • HIW Real Estate Investment Trusts
  • Sector
  • XENE Health Care
  • HIW Real Estate
  • Exchange
  • XENE Nasdaq
  • HIW Nasdaq
  • Market Cap
  • XENE 3.3B
  • HIW 3.1B
  • IPO Year
  • XENE 2014
  • HIW 1994
  • Fundamental
  • Price
  • XENE $38.52
  • HIW $30.24
  • Analyst Decision
  • XENE Strong Buy
  • HIW Hold
  • Analyst Count
  • XENE 7
  • HIW 7
  • Target Price
  • XENE $56.00
  • HIW $30.86
  • AVG Volume (30 Days)
  • XENE 424.9K
  • HIW 944.6K
  • Earning Date
  • XENE 02-27-2025
  • HIW 02-11-2025
  • Dividend Yield
  • XENE N/A
  • HIW 6.62%
  • EPS Growth
  • XENE N/A
  • HIW 3.74
  • EPS
  • XENE N/A
  • HIW 1.34
  • Revenue
  • XENE N/A
  • HIW $829,290,000.00
  • Revenue This Year
  • XENE N/A
  • HIW N/A
  • Revenue Next Year
  • XENE $1,600.08
  • HIW $0.14
  • P/E Ratio
  • XENE N/A
  • HIW $22.61
  • Revenue Growth
  • XENE N/A
  • HIW N/A
  • 52 Week Low
  • XENE $35.53
  • HIW $21.46
  • 52 Week High
  • XENE $50.99
  • HIW $36.78
  • Technical
  • Relative Strength Index (RSI)
  • XENE 42.98
  • HIW 50.01
  • Support Level
  • XENE $36.90
  • HIW $29.73
  • Resistance Level
  • XENE $41.03
  • HIW $30.29
  • Average True Range (ATR)
  • XENE 1.41
  • HIW 0.65
  • MACD
  • XENE 0.03
  • HIW 0.09
  • Stochastic Oscillator
  • XENE 30.39
  • HIW 76.28

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.

About HIW Highwoods Properties Inc.

Highwoods Properties Inc is a real estate investment trust engaged in the acquisition, ownership, management, and leasing of properties in urban areas throughout the Southern United States. In terms of total square footage, the vast majority of the company's real estate portfolio comprises office buildings in terms. Highwoods Properties derives nearly all of its income in the form of rental revenue from the tenants of its buildings. The majority of this revenue comes from its holdings in the urban markets of Atlanta, Raleigh, Nashville, and Tampa. These cities also account for the majority of the square footage under the company's ownership. Highwoods Properties' largest customers include the U.S. Government, financial services firms, industrial supply retailers, and healthcare companies.

Share on Social Networks: